Ping Ye
18Patents
7h-index
31Co-inventors
62Inventor score
Filing activity: Jun 19, 2008 → Jun 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8232285B2 | Quinazolinone compounds and methods of use thereof | Human Necessities | 19 | Active |
| US10106579B2 | Modulation of complement activity | Emerging Cross-Sectional Technologies | 10 | Active |
| US10328115B2 | Modulators of complement activity | Chemistry; Metallurgy | 10 | Active |
| US10208089B2 | Modulation of complement activity | Emerging Cross-Sectional Technologies | 9 | Active |
| US9937222B2 | Modulators of complement activity | Chemistry; Metallurgy | 9 | Active |
| US10588936B2 | Modulators of complement activity | Chemistry; Metallurgy | 9 | Active |
| US10435438B2 | Modulation of complement activity | Emerging Cross-Sectional Technologies | 9 | Active |
| US10918691B2 | Modulators of complement activity | Chemistry; Metallurgy | 2 | Active |
| US9238676B2 | Peptide and peptidomimetic inhibitors | Human Necessities | 1 | Active |
| US10954287B2 | Ras binding peptides and methods of use | Physics | 1 | Active |
| US11014965B2 | Modulation of complement activity | Emerging Cross-Sectional Technologies | 1 | Active |
| US10272132B2 | Peptide and peptidomimetic inhibitors | Human Necessities | 1 | Active |
| US9644004B2 | Peptide and peptidomimetic inhibitors | Human Necessities | 1 | Active |
| US9999650B2 | Peptide and peptidomimetic inhibitors | Human Necessities | 0 | Active |
| US11965040B2 | Modulation of complement activity | Emerging Cross-Sectional Technologies | 0 | Active |
| US11535650B1 | Modulation of complement activity | Emerging Cross-Sectional Technologies | 0 | Active |
| US12239684B2 | Modulators of complement activity | Chemistry; Metallurgy | 0 | Active |
| US11707503B2 | Modulators of complement activity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.